Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains
Shots:
- Qiagen’s QIAseq SARS-CoV-2 primer panel provides optimized- single-day workflows to prepare libraries for sequencing as researchers use NGS to track changes in the viral genome
- The two-step process uses advanced QIAseq technologies to conduct reverse transcription and cDNA synthesis from a viral RNA sample- then generate libraries compatible with Illumina sequencing platforms
- The solution aims to accelerate research into COVID-19 prevention and treatment by enabling deeper and more holistic insights into the biology of SARS-CoV-2
Ref: Qiagen | Image: Euronews
Click here to read the full press release
Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at [email protected]
